Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen exclusion is **not a specific molecule, receptor, or canonical therapeutic target**. Instead, it refers to a broad set of biological and behavioral mechanisms by which organisms prevent pathogens from entering the body or establishing infection. In immunology and evolutionary biology, "pathogen exclusion" (also called pathogen avoidance) describes strategies—ranging from physical barriers (like skin and mucosa), innate immune responses (such as pattern recognition receptors), to complex behaviors (such as disgust-driven avoidance)—that reduce exposure to infectious agents[5][4][6]. These mechanisms are not mediated by a single protein or gene but involve multiple systems working together to minimize contact with pathogens.\n\nIn humans and animals, pathogen exclusion includes both physiological processes (e.g., immune system barriers) and psychological/behavioral adaptations that help avoid sources of infection[5]. For example, the behavioral immune system triggers aversion responses toward cues associated with disease risk. At the molecular level in plants and animals, various proteins—including pattern-recognition receptors—detect pathogens early to trigger defensive responses[4].\n\nBecause "pathogen exclusion" is not an individual molecule or druggable target but rather a general process involving many components across different biological levels, it does **not fit standard definitions for molecular targets such as receptors or enzymes**. Therefore:\n\n- It has no canonical abbreviation.\n- It is not considered a direct therapeutic target.\n- There are no specific drugs that interact directly with "pathogen exclusion."\n- There are no unique biomarkers for this process alone.\n\nIf you require information on specific molecules involved in pathogen detection/exclusion—such as pattern-recognition receptors (PRRs), toll-like receptors (TLRs), or other innate immunity factors—please specify so more targeted data can be provided[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen exclusion.